Grasso P, Rozhavskaya M, Reichert L E
Department of Biochemistry and Molecular Biology, Albany Medical College, New York 12208, USA.
Endocrinology. 1997 Oct;138(10):4215-9. doi: 10.1210/endo.138.10.5271.
We have previously reported that a synthetic peptide amide corresponding to residues 34-37 (TRDL, threonine, arginine-aspartic acid-leucine) of the beta-subunit of human FSH induced prolonged vaginal estrus in normally cycling female mice (see Ref. 15). These results represented the first demonstration of an in vivo effect of a gonadotropin-related synthetic peptide on reproductive processes. We have extended these studies to examine possible effects of TRDL on the onset of puberty in female mice. In two replicated experiments, vehicle-injected control mice attained first vaginal estrus by day 39. An ip injection of 200 ug TRDL/g BW to 28-day-old prepubertal female mice, however, accelerated the onset of first vaginal estrus by 7 days in 11 of 12 (11/12) (Exp 1) and 7/9 (Exp 2) mice. Serum estradiol levels were significantly (P = 0.017) elevated in TRDL-treated mice, whereas progesterone was unchanged. Uteri of TRDL-treated mice were significantly (P = 0.003) heavier than uteri of vehicle-injected control animals of the same age and body weight. Intraluminal fluid accumulation (ballooning) at proestrus was absent in 20/21 TRDL-treated females, as were oviductal ova and ovarian corpora lutea. These phenomena are characteristic of the first estrous cycles of female mice isolated from males. To obtain further evidence for in vivo effects of TRDL, we assessed the ability of TRDL to accelerate the onset of puberty in male mice. When given as five consecutive daily ip injections of 200 ug/g BW to 28-day-old prepubertal male mice, TRDL significantly increased testis weight, when compared with vehicle-injected control mice of the same age and BW (171.3 +/- 3.8 mg vs. 151.6 +/- 4.3 mg, P = 0.001) and induced a 6.5-fold increase in serum testosterone levels. These studies confirm the previously reported in vivo activity of a synthetic peptide corresponding to human FSH-beta subunit 34-37 (TRDL) in adult female mice and extend its effects to the acceleration of the onset of puberty in immature male and female mice.
我们之前曾报道,一种与人类促卵泡激素β亚基34 - 37位残基(TRDL,苏氨酸 - 精氨酸 - 天冬氨酸 - 亮氨酸)相对应的合成肽酰胺可使正常发情周期的雌性小鼠出现延长的阴道发情期(见参考文献15)。这些结果首次证明了促性腺激素相关合成肽对生殖过程的体内作用。我们扩展了这些研究,以检验TRDL对雌性小鼠青春期启动的可能影响。在两项重复实验中,注射赋形剂的对照小鼠在第39天出现首次阴道发情。然而,对28日龄青春期前雌性小鼠腹腔注射200μg TRDL/g体重,在实验1的12只小鼠中有11只(11/12)、实验2的9只小鼠中有7只(7/9)首次阴道发情的启动提前了7天。TRDL处理组小鼠的血清雌二醇水平显著升高(P = 0.017),而孕酮水平未变。TRDL处理组小鼠的子宫明显比同年龄、同体重的注射赋形剂对照动物的子宫重(P = 0.003)。21只接受TRDL处理的雌性小鼠中有20只在动情前期没有出现管腔积液(肿胀),输卵管卵子和卵巢黄体也未出现。这些现象是与雄性隔离的雌性小鼠首次发情周期的特征。为了获得TRDL体内作用的进一步证据,我们评估了TRDL加速雄性小鼠青春期启动的能力。当对28日龄青春期前雄性小鼠连续5天每天腹腔注射200μg/g体重的TRDL时,与同年龄、同体重的注射赋形剂对照小鼠相比,TRDL显著增加了睾丸重量(171.3±3.8mg对151.6±4.3mg,P = 0.001),并使血清睾酮水平提高了6.5倍。这些研究证实了之前报道的与人类促卵泡激素β亚基34 - 37位残基相对应的合成肽(TRDL)在成年雌性小鼠中的体内活性,并将其作用扩展到加速未成熟雄性和雌性小鼠青春期的启动。